Research Fellow develops the strategy and vision to position a project from inception through completion; creates teams and collaborations that understand the project's direction. Communicates direction through words or actions to inspire team members to reach goals. Being a Research Fellow also responsible for planning and budgeting. Requires a PhD in their field of specialty. Additionally, Research Fellow typically reports to a top management. The Research Fellow manages a departmental sub-function within a broader departmental function. Creates functional strategies and specific objectives for the sub-function and develops budgets/policies/procedures to support the functional infrastructure. To be a Research Fellow typically requires 5+ years of managerial experience. Deep knowledge of the managed sub-function and solid knowledge of the overall departmental function. (Copyright 2024 Salary.com)
The Postdoctoral Research Fellow, Multiple Myeloma is in the field of cancer immunotherapy with a focus on the gut microbiome in the laboratory of Dr. Rena Feinman. The long-term goal of the laboratory's research program is to identify unique microbiota-associated immunomodulatory biomarkers that predict refractory disease and early relapse in patients with multiple myeloma. The successful postdoctoral candidate should have a strong interest in the microbiome, cancer biology and immuno-oncology. The candidate will perform in vivo animal models, in vitro assays and bioinformatic analyses. The postdoctoral fellow is expected to understand the project and work independently taking responsibilities in the development and execution of experimental procedures to successfully advance the research project. The successful candidate will be responsible for preparing data for presentations, progress reports, and the preparation of manuscripts and posters. The post-doctoral fellow is anticipated to have good communication and writing skills, as well as a mindset for collaborative research.
The Center for Discovery and Innovation (CDI), was established by Hackensack Meridian Health (HMH) as an academic basic and translational research enterprise to rapidly translate science innovation to the clinic to improve outcomes for patients with cancer, infectious diseases, autoimmune disease and other acute and chronic diseases. The CDI has grown rapidly since its origins in 2019, and now has 18 labs, 150 scientists and support personnel, who are supported by more than 85 grants and contracts. Areas of expertise include genomics, epigenetics, drug resistance, stem cell biology, drug discovery, diagnostics and biomarker development, and pharmacology.